Dr’s Warn About Side Effect Of Weight Loss Drugs As More Users Go blind

Experts have sounded the alarm about popuar weight loss drugs like Ozempic that are leaving users blind.

While doctors warn about the startling side effects experienced by Americans on the weight loss drugs, the UK government, in all its wisdom, wants unemployed people to be given the weight loss jabs in order to ‘get them back to work’.

A number of studies have linked the shots to conditions that cause inflammation and block blood flow to the eye, causing severe and sometimes permanent vision loss.

Now, researchers have detailed nine new reports of patients in the US who went blind after taking semaglutide or tirzepatide, the active ingredients in Ozempic and Mounjaro, respectively.

The Mail Online reports: One woman injected one dose of semaglutide for her diabetes and woke up the next morning blind in her left eye.

This prompted her to stop the medication for two months before her diabetes forced her to go back on it. Two weeks after restarting, she lost vision in her right eye as well.

Another woman who had been taking semaglutide for a year woke up one morning with a ‘painless shadow’ over her left eye. Testing revealed blood vessels in her retina had become damaged, leading to blindness.

And one suffered bleeding in his left eye after taking tirzepatide for a year. However, doctors told him to keep taking the drug due to a lack of evidence linking his condition to weight loss shots.

The experts said while the exact cause is unclear, drugs like Ozempic rapidly lowering blood sugar levels could damage blood vessels in the eyes, leading to vision loss.

Health officials in Denmark, where Ozempic maker Novo Nordisk is based, is currently investigating the links between semaglutide and vision loss.

The new report detailed the cases of nine adults taking either semaglutide or tirzepatide.

The average patient age was 57, and the majority (56 percent) were women.

The patients were from Utah, Minnesota, New York, West Virginia, and Ohio.

The researchers found seven patients were diagnosed with nonarteritic ischemic anterior optic neuropathy (NAION), a condition where blood flow to the optic nerve gets blocked. The optic nerve helps transmit visual information from the eye’s retina to the brain.

This leads to sudden vision loss in one or both eyes